The 2016 revision of the World Health Organization classification of lymphoid neoplasms
نویسندگان
چکیده
Oncology, Milan, and Department of Experimental, Diagnostic and Specialty Medicine, Bologna University Medical School, Bologna, Italy; Department of Pathology, Harvard Medical School and Massachusetts General Hospital, Boston, MA; Pathodiagnostik, Berlin, Germany; Institute of Human Genetics, Christian Albrechts University Kiel, Kiel, Germany; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA; Department of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Department of Hematology, Hospices Civils de Lyon, and
منابع مشابه
The 2016 revision of the World Health Organization ( WHO ) classification of lymphoid neoplasms
word count: 125
متن کاملIntroduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues.
c Daniel A. Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J. Borowitz, Michelle M. Le Beau, Clara D. Bloomfield, Mario Cazzola, and James W. Vardiman, “The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia” c Steven H. Swerdlow, Elias Campo, Stefano A. Pileri, Nancy Lee Harris, Harald Stein, Reiner Siebert, Ranjana Advani, Mi...
متن کاملThe 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues was last updated in 2008. Since then, there have been numerous advances in the identification of unique biomarkers associated with some myeloid neoplasms and acute leukemias, largely derived from gene expression analysis and next-generation sequencing that can significantly improve the diagnos...
متن کامل[Decipher the 2016 revision of the World Health Organization classification of lymphoid neoplasms].
The European Society of Pathology and the Society for Hematopathology have developed a new World Health Organization (WHO) classification of hematological malignancies. The classification is based on the principle that the classification is a list of entities defined by the combination of morphology, immunophenotype, genetic and clinical features. The WHO classification is a new basis of commun...
متن کاملHyper eosinophilia associated with myeloid and lymphoid neoplasms
Eosinophilia in the absence of allergies, asthma, drug reactions, parasitic infections and connective tissue diseases can be eosinophilic clonal disorders, lymphoma or myeloproliferative disorders. Hypereosinophilia with the persistence of eosinophils ≥1500 /mm³ in blood or more than 20% of eosinophils in the bone marrow may be observed in many reactive or clonal disorders, the result of which ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2016